Table of Contents
1 PEGylated Protein Therapeutics Market Overview
1.1 Product Overview and Scope of PEGylated Protein Therapeutics
1.2 Classification of PEGylated Protein Therapeutics by Type
1.2.1 Global PEGylated Protein Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global PEGylated Protein Therapeutics Revenue Market Share by Type in 2019
1.2.3 Colony Stimulating Factor
1.2.4 Interferon
1.2.5 Erythropoietin (EPO)
1.2.6 Recombinant Factor VIII
1.2.7 Monoclonal Antibody
1.2.8 Enzyme
1.2.9 Others
1.3 Global PEGylated Protein Therapeutics Market by Application
1.3.1 Overview: Global PEGylated Protein Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Autoimmune Disease
1.3.4 Hepatitis
1.3.5 Multiple Sclerosis
1.3.6 Hemophilia
1.3.7 Gastrointestinal Disorder
1.3.8 Others
1.4 Global PEGylated Protein Therapeutics Market by Regions
1.4.1 Global PEGylated Protein Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of PEGylated Protein Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 UCB
2.6.1 UCB Details
2.6.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UCB SWOT Analysis
2.6.4 UCB Product and Services
2.6.5 UCB PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biogen SWOT Analysis
2.7.4 Biogen Product and Services
2.7.5 Biogen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Leadiant Biosciences
2.9.1 Leadiant Biosciences Details
2.9.2 Leadiant Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Leadiant Biosciences SWOT Analysis
2.9.4 Leadiant Biosciences Product and Services
2.9.5 Leadiant Biosciences PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global PEGylated Protein Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 PEGylated Protein Therapeutics Players Market Share
3.2.2 Top 10 PEGylated Protein Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global PEGylated Protein Therapeutics Revenue and Market Share by Regions
4.2 North America PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
5 North America PEGylated Protein Therapeutics Revenue by Countries
5.1 North America PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
5.2 USA PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe PEGylated Protein Therapeutics Revenue by Countries
6.1 Europe PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
6.2 Germany PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific PEGylated Protein Therapeutics Revenue by Countries
7.1 Asia-Pacific PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
7.2 China PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
8 South America PEGylated Protein Therapeutics Revenue by Countries
8.1 South America PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue PEGylated Protein Therapeutics by Countries
9.1 Middle East & Africa PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global PEGylated Protein Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global PEGylated Protein Therapeutics Market Forecast by Type (2019-2024)
10.3 Colony Stimulating Factor Revenue Growth Rate (2015-2025)
10.4 Interferon Revenue Growth Rate (2015-2025)
10.5 Erythropoietin (EPO) Revenue Growth Rate (2015-2025)
10.6 Recombinant Factor VIII Revenue Growth Rate (2015-2025)
10.7 Monoclonal Antibody Revenue Growth Rate (2015-2025)
10.8 Enzyme Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global PEGylated Protein Therapeutics Market Segment by Application
11.1 Global PEGylated Protein Therapeutics Revenue Market Share by Application (2015-2020)
11.2 PEGylated Protein Therapeutics Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Autoimmune Disease Revenue Growth (2015-2020)
11.5 Hepatitis Revenue Growth (2015-2020)
11.6 Multiple Sclerosis Revenue Growth (2015-2020)
11.7 Hemophilia Revenue Growth (2015-2020)
11.8 Gastrointestinal Disorder Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global PEGylated Protein Therapeutics Market Size Forecast (2021-2025)
12.1 Global PEGylated Protein Therapeutics Market Size Forecast (2021-2025)
12.2 Global PEGylated Protein Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
【掲載企業】
Merck、Horizon Pharma、Amgen、Pfizer、Roche、UCB、Biogen、AstraZeneca、Leadiant Biosciences
【免責事項】
https://www.globalresearch.jp/disclaimer